Your browser doesn't support javascript.
loading
Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers.
Naryzhny, Stanislav; Ronzhina, Natalia; Zorina, Elena; Kabachenko, Fedor; Klopov, Nikolay; Zgoda, Victor.
Afiliação
  • Naryzhny S; Institute of Biomedical Chemistry, Pogodinskaya, 10, 119121 Moscow, Russia.
  • Ronzhina N; Petersburg Institute of Nuclear Physics (PNPI) of National Research Center "Kurchatov Institute", 188300 Gatchina, Russia.
  • Zorina E; Petersburg Institute of Nuclear Physics (PNPI) of National Research Center "Kurchatov Institute", 188300 Gatchina, Russia.
  • Kabachenko F; Institute of Biomedical Chemistry, Pogodinskaya, 10, 119121 Moscow, Russia.
  • Klopov N; Institute of Biomedical Systems and Biotechnology, Peter the Great St. Petersburg Polytechnic University, 195251 St. Petersburg, Russia.
  • Zgoda V; Petersburg Institute of Nuclear Physics (PNPI) of National Research Center "Kurchatov Institute", 188300 Gatchina, Russia.
Int J Mol Sci ; 23(19)2022 Sep 21.
Article em En | MEDLINE | ID: mdl-36232415
The use of tumor markers aids in the early detection of cancer recurrence and prognosis. There is a hope that they might also be useful in screening tests for the early detection of cancer. Here, the question of finding ideal tumor markers, which should be sensitive, specific, and reliable, is an acute issue. Human plasma is one of the most popular samples as it is commonly collected in the clinic and provides noninvasive, rapid analysis for any type of disease including cancer. Many efforts have been applied in searching for "ideal" tumor markers, digging very deep into plasma proteomes. The situation in this area can be improved in two ways-by attempting to find an ideal single tumor marker or by generating panels of different markers. In both cases, proteomics certainly plays a major role. There is a line of evidence that the most abundant, so-called "classical plasma proteins", may be used to generate a tumor biomarker profile. To be comprehensive these profiles should have information not only about protein levels but also proteoform distribution for each protein. Initially, the profile of these proteins in norm should be generated. In our work, we collected bibliographic information about the connection of cancers with levels of "classical plasma proteins". Additionally, we presented the proteoform profiles (2DE patterns) of these proteins in norm generated by two-dimensional electrophoresis with mass spectrometry and immunodetection. As a next step, similar profiles representing protein perturbations in plasma produced in the case of different cancers will be generated. Additionally, based on this information, different test systems can be developed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoma / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoma / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article